Literature DB >> 343713

Hemodialysis-associated infections: treatment with cephapirin.

S J Berman, W H Boughton, J G Sugihara, E G Wong, A W Siemsen.   

Abstract

Large doses of cephapirin (50 mg/kg) administered during the first and last half hours of routine hemodialysis produced effective antimicrobial serum concentrations for 48 h. Repetitive administration during five successive hemodialysis sessions did not result in accumulation or accelerated metabolism of cephapirin. Ten infectious episodes in nine patients were treated in this manner with good clinical results and no toxicity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 343713      PMCID: PMC352175          DOI: 10.1128/AAC.13.1.4

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

Review 1.  Pharmacokinetics and clinical use of cephalosporin antibiotics.

Authors:  C H Nightingale; D S Greene; R Quintiliani
Journal:  J Pharm Sci       Date:  1975-12       Impact factor: 3.534

2.  Adverse reactions to cephalothin and cephapirin. Uniform occurrence on prolonged intravenous administration of high doses.

Authors:  W E Sanders; J E Johnson; J G Taggart
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

Review 3.  The cephalosporins. Microbiological, chemical, and pharmacological properties and use in chemotherapy of infection.

Authors:  L Weinstein; K Kaplan
Journal:  Ann Intern Med       Date:  1970-05       Impact factor: 25.391

4.  Effect of hemodialysis and renal failure on serum and urine concentrations of cephapirin sodium.

Authors:  R V McCloskey; E E Terry; A W McCracken; M J Sweeney; M F Forland
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

5.  Excretion of cephaloridine and cephalothin in patients with renal impairment.

Authors:  C M Kunin; N Atuk
Journal:  N Engl J Med       Date:  1966-03-24       Impact factor: 91.245

6.  Evaluation of a new cephalosporin antibiotic, cephapirin.

Authors:  P Wiesner; R MacGregor; D Bear; S Berman; K Holmes; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

  6 in total
  3 in total

1.  Pharmacokinetics of ceforanide in patients with end stage renal disease on hemodialysis.

Authors:  J R Hess; S J Berman; W H Boughton; J G Sugihara; J E Musgrave; E G Wong; A M Siemsen
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

Review 2.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

3.  Microbial degradation of cephalothin by cephalothin-susceptible Escherichia coli.

Authors:  T Nishiura; Y Kawada; Y Shiomi; K O'Hara; M Kono
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.